Search results (15)
« Back to NewsGround-breaking Study reveals previously unknown genetic causes of Colorectal Cancer
7 August 2024
A pioneering study, led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the University of Manchester and the University of Leeds, has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC).
Glowing dye helps surgeons eradicate prostate cancer
10 June 2024
A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.
New funding for development of world's first lung cancer vaccine
22 March 2024
Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.
Prof Anna Schuh launches first private specialised haematology clinic and laboratory in sub-Saharan Africa.
23 October 2023
SerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.
Professor Eileen Parkes appointed to lead Oxford’s Experimental Cancer Medicine Centre
17 October 2023
Eileen Parkes, Associate Professor in Innate Tumour Immunology in the Department of Oncology, will lead the expansion of the centre’s programmes in early drug development and biomarker research.
Multi-cancer blood test shows real promise in NHS trial
2 June 2023
An NHS trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5,000 people who had visited their GP with suspected symptoms, in England or Wales. The test also correctly identified the original site of cancer in 85% of those cases.
Oxford gets £122m funding for healthcare research
14 October 2022
Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the city’s two National Institute for Health and Care Research (NIHR) Biomedical Research Centres (BRC).
OUH agrees long COVID research collaboration with Polarean
18 May 2022
The collaboration will look at understanding the long-term effects of COVID-19 through cutting-edge MRI analysis.
Lung abnormalities found in long COVID patients with breathlessness
29 January 2022
Researchers have identified abnormalities in the lungs of long COVID patients who are experiencing breathlessness that cannot be detected with routine tests.
Advancing radiotherapy technology through clinical trials
19 November 2021
Rob Stepney participated in a radiotherapy clinical trial in Oxford in 2021. He talks about his experience on the trial and accessing a state-of-the-art machine that uses real-time imaging to improve tumour targeting.
Oxford cancer clinical trials unit receives acclaimed nursing award
13 October 2021
The nursing team at the Early Phase Clinical Trials Unit has been awarded the Excellence in Cancer Research Nursing Award 2021.
Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS
15 September 2021
A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.
Hidden lung damage from COVID-19 revealed in new study
2 December 2020
Early findings from a study into longer-term damage amongst patients recovering from COVID-19 suggest that the use of cutting-edge scanning techniques may detect previously unseen lung damage.
Professor Sibson secures further MRC DPFS funding
20 October 2020
Prof. Sibson together with her co-applicants Prof. Anthony, Dr Campbell and Prof. Middleton have now been awarded a second MRC DPFS grant, for £3.3 million, to acquire further preclinical data to support the case for clinical translation, to develop the mutTNF production for human use and to undertake pre-clinical toxicology.
New digital classification method using AI developed for colorectal cancer
22 July 2020
Understanding the molecular subtype of a cancer is becoming an importance part of the diagnostic process as it helps a doctor better understand a patient’s prognosis, determine the best course of action for treatment and helps researchers devise new, more-efficient, precision therapies.